Ahmedabad based Torrent Pharma has acquired two gynaecology products from Switzerland-based Novartis AG for an undisclosed amount. “The company has completed the acquisition of Regestrone and Pregachieve brands for India from global pharma player Novartis AG,” said Torrent Pharma yesterday in a press statement. These brands are widely prescribed by gynaecologists for the management of abnormal uterine bleeding, peri & post- menopausal symptoms and infertility.
Women healthcare is an important therapy area for Torrent Pharma, which it intends to focus in the future. With acquisition of key brands of Elder like Shelcal and Deviry, impetus on this therapy area has also